News and blogs
413 results found.
Leukaemia treatment: test could predict response
The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed.
CAR-T access in Scotland for childhood leukaemia
Children and young people in Scotland with ALL who relapse after standard treatments will be able to access the CAR-T cell therapy Kymriah.
Two breakthroughs in CAR-T therapy
First child with acute lymphoblastic leukaemia (ALL) receives CAR-T therapy on the NHS and the treatment is made available to adult lymphoma patients.
Delays in blood cancer diagnosis 'avoidable'
A new report has found that many patients with lymphoma take longer to be diagnosed than expected, and some think these delays could have been avoided
How a virus can lead to lymphoma trial
Our researcher has been investigating how a virus that causes lymphoma increases the production of this cancer-driving microRNA. Find out more.
Blood Cancer UK research highlights 2018
From CAR-T therapy to a new understanding of how leukaemia develops in children. We look back at some of the breakthroughs our supporters help us fund.
Childhood blood cancer deaths halved in 15 years
Blood Cancer UK data on cancer deaths show the number of children and young adults dying from blood cancer has halved in the last 15 years.
How gene mutations cause blood cancers
Blood Cancer UK scientists at the University of Birmingham have revealed the roles that different types of gene mutations play in causing blood cancers.
New leukaemia treatment in Scotland
A targeted drug that improves survival for people with an aggressive type of blood cancer will be made available on the NHS in Scotland.
CAR-T therapies hold promise for cancers
Immunotherapy treatments called CAR-T therapies involve reprogramming a type of ‘supercharged’ immune cell could be mass-produced to help fight cancer.
Through the eye of a needle: Molecular immunology and anti-cancer drugs
Finding drugs that can target cancer cells but leave healthy cells unharmed is an ongoing problem in cancer research. At the University of Oxford, Professor Terry Rabbitts is exploring ways to create targeted drugs that work by blocking blood cancer proteins from interacting with healthy proteins – and the technique he’s developed for making these drugs could also have an impact on many other diseases. Read on to find out more…
Governments new blood cancer strategy to save lives
Theresa May announced a new cancer strategy today that aims to save thousands of lives each year in England by speeding up cancer diagnosis.
Casualty star shares training tips for big run
George Rainsford, who plays Ethan Hardy in Casualty and has starred in Call the Midwife, shares his advice for running training while managing a busy life.
CAR-T treatment turned down on NHS
The NHS medicines watchdog has recommended that a treatment called Kymriah should not be available to people with diffuse large B-cell lymphoma (DLBCL).
Last day of leukaemia treatment for Hugo
Hugo was diagnosed with leukaemia in 2015 at the age of two. After three years of gruelling chemotherapy, his treatment finishes today.
Brits don’t know blood cancer symptoms
Only 1 in 10 people are confident they know the common symptoms of blood cancer despite it being one of the most commonly diagnosed cancers in the UK.
Blood cancer patients may be denied CAR-T
Draft guidance by the NHS medicines watchdog recommends a new treatment that harnesses the immune system to fight cancer should not be available.
Blood cancer patients least likely to understand their diagnosis
How MPN disrupt work of blood stem cells
Blood Cancer UK researchers discover blood stem cells need to strike a delicate balance between making other types of blood cells and renewing themselves.
CLL - more people to benefit from ibrutinib in future
More people living with a type of leukaemia in England will soon have access to Ibrutinib, thanks to a successful campaign by Blood Cancer UK.